We are live on
!
Find out more
SPA
Sherbrooke Park Advisers Portfolio holdings
AUM
$38.7M
1-Year Est. Return
5.29%
This Fund
S&P 500
This Quarter
Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
(+7.3%)
Cap. Flow
+$5.46M
Cap. Flow
% of AUM
2.37%
Top 10 Holdings %
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$1.45M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.42M |
| 3 |
Genpact
G
|
+$1.42M |
| 4 |
C.H. Robinson
CHRW
|
+$1.34M |
| 5 |
OGE Energy
OGE
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.44M |
| 2 |
Mondelez International
MDLZ
|
+$1.42M |
| 3 |
Avnet
AVT
|
+$1.21M |
| 4 |
Marvell Technology
MRVL
|
+$1.04M |
| 5 |
XYZ
Block Inc
XYZ
|
+$987K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.25% |
| 2 | Consumer Discretionary | 15.35% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 12.99% |
| 5 | Financials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Yelp
YELP
$1.41B
| $217K | 0.09% |
+6,336
| New | +$229K |
|
377
Evertec
EVTC
$1.78B
| $215K | 0.09% |
5,973
-2,529
| -30% | -$89.6K |
|
378
Remitly
RELY
$5.14B
| $215K | 0.09% |
11,448
-261
| -2% | -$5.43K |
|
379
Donegal Group Class A
DGICA
$714M
| $214K | 0.09% |
+10,711
| New | +$208K |
|
380
Progyny
PGNY
$2.2B
| $214K | 0.09% |
+9,734
| New | +$214K |
|
381
Lands' End
LE
$403M
| $213K | 0.09% |
+19,903
| New | +$180K |
|
382
Lindsay Corp
LNN
$1.18B
| $210K | 0.09% |
+1,453
| New | +$194K |
|
383
Celsius Holdings
CELH
$7.03B
| $209K | 0.09% |
4,511
-21,652
| -83% | -$834K |
|
384
Sprout Social
SPT
$621M
| $208K | 0.09% |
+9,965
| New | +$211K |
|
385
Broadcom
AVGO
$2.04T
| $208K | 0.09% |
755
-4,127
| -85% | -$896K |
|
386
Intuitive Machines
LUNR
$2.63B
| $208K | 0.09% |
+19,133
| New | +$187K |
|
387
Diamondback Energy
FANG
$52.7B
| $208K | 0.09% |
+1,512
| New | +$209K |
|
|
ADAM
388
Adamas Trust
ADAM
$883M
| $207K | 0.09% |
+30,902
| New | +$196K |
|
389
Dropbox
DBX
$8.12B
| $205K | 0.09% |
+7,172
| New | +$203K |
|
390
Lindblad Expeditions
LIND
$2.22B
| $205K | 0.09% |
+17,554
| New | +$174K |
|
391
Kraft Heinz
KHC
$30B
| $205K | 0.09% |
+7,930
| New | +$220K |
|
392
Whirlpool
WHR
$2.82B
| $204K | 0.09% |
+2,010
| New | +$167K |
|
393
XPEL
XPEL
$1.38B
| $203K | 0.09% |
+5,664
| New | +$187K |
|
394
Toll Brothers
TOL
$14.5B
| $202K | 0.09% |
+1,767
| New | +$183K |
|
395
First Citizens BancShares
FCNCA
$25.3B
| $202K | 0.09% |
103
-171
| -62% | -$310K |
|
396
Greif
GEF
$5.04B
| $201K | 0.09% |
+3,098
| New | +$176K |
|
397
Alignment Healthcare
ALHC
$2.98B
| $200K | 0.09% |
14,309
-3,953
| -22% | -$63.6K |
|
398
Kontoor Brands
KTB
$4.26B
| $200K | 0.09% |
+3,036
| New | +$196K |
|
399
Annaly Capital Management
NLY
$17.4B
| $197K | 0.09% |
10,485
-2,600
| -20% | -$49.4K |
|
400
Fortrea Holdings
FTRE
$1.75B
| $193K | 0.08% |
39,157
-4,582
| -10% | -$24.6K |
|
Similar funds
2C
SIM
ISSM
KCM
EFI
ICM
APM
CI
Sherbrooke Park Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.
Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
- Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
- Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
- Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
- Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
- Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
- Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.
Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.